John W Hubbard
CIK 1622323 · Director · last filed 2024-08-26
John W Hubbard is a Director who has filed 16 SEC Form 4 insider transactions across 2 companies since 2014.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
2
Total Filings
16
Lifetime Open-Market Net
$0
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Science 37 Holdings, Inc. (SNCE) Delisted | Director | 0 | $5.75 | $0 | $0 | 5 | 2024-03-12 |
| AGILE THERAPEUTICS INC (AGRX) Delisted | Director | 976 | $1.51 | $1.5K | $0 | 10 | 2023-06-09 |
Recent Filings
16 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-08-26 | — | Disp (D) | −976 | -$1.5K | |
| 2024-03-12 | Science 37 Holdings, Inc. (SNCE) Delisted | Mixed | −2,050 | -$11.8K | EDGAR |
| 2023-06-09 | AGILE THERAPEUTICS INC (AGRX) Delisted | Grant (A) | +935 | $0 | EDGAR |
| 2023-05-12 | Science 37 Holdings, Inc. (SNCE) Delisted | Mixed | +40,983 | $0 | EDGAR |
| 2022-06-10 | AGILE THERAPEUTICS INC (AGRX) Delisted | Grant (A) | +670 | $0 | EDGAR |
| 2022-05-24 | Science 37 Holdings, Inc. (SNCE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-10-12 | Science 37 Holdings, Inc. (SNCE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-10-08 | Science 37 Holdings, Inc. (SNCE) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-10 | AGILE THERAPEUTICS INC (AGRX) Delisted | Grant (A) | +24,510 | $0 | EDGAR |
| 2020-06-11 | AGILE THERAPEUTICS INC (AGRX) Delisted | Grant (A) | +13,393 | $0 | EDGAR |
Showing 1–10 of 16
Page 1 of 2
Next
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.